Abstract
Human papillomaviruses (HPVs) are involved in the pathogenesis of cancer of the cervix (CaCx). MicroRNA (miRNA) expression analysis using Ambion (Austin, TX, USA) arrays showed that three miRNAs were overexpressed and 24 underexpressed in cervical cell lines containing integrated HPV-16 DNA compared to the normal cervix. Furthermore, nine miRNAs were overexpressed and one underexpressed in integrated HPV-16 cell lines compared to the HPV-negative CaCx cell line C-33A. Based on microarray and/or quantitative real-time PCR and northern blot analyses, microRNA-218 (miR-218) was specifically underexpressed in HPV-positive cell lines, cervical lesions and cancer tissues containing HPV-16 DNA compared to both C-33A and the normal cervix. Expression of the E6 oncogene of high-risk HPV-16, but not that of low-risk HPV-6, reduced miR-218 expression, and conversely, RNA interference of E6/E7 oncogenes in an HPV-16-positive cell line increased miR-218 expression. We also demonstrate that the epithelial cell-specific marker LAMB3 is a target of miR-218. We also show that LAMB3 expression is increased in the presence of the HPV-16 E6 oncogene and this effect is mediated through miR-218. These findings may contribute to a better understanding of the molecular mechanisms involved in cervical carcinogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- CaCx:
-
cancer of the cervix
- HPVs:
-
human papillomaviruses
- miRNA:
-
microRNA
References
Alazawi W, Pett M, Arch B, Scott L, Freeman T, Stanley MA et al. (2002). Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16. Cancer Res 62: 6959–6965.
Band V, Dalal S, Delmolino L, Androphy EJ . (1993). Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J 12: 1847–1852.
Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N et al. (2006). Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29–38.
Calaluce R, Bearss DJ, Barrera J, Zhao Y, Han H, Beck SK et al. (2004). Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia 6: 468–479.
Calin GA, Croce CM . (2006). MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390–7394.
Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND . (2006). Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80: 8940–8950.
Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz Jr LA, Sjoblom T et al. (2006). The colorectal microRNAome. Proc Natl Acad Sci USA 103: 3687–3692.
Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ et al. (2003). NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421: 639–643.
Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, Maher ER et al. (2002). SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 62: 5874–5880.
Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S et al. (2000). The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 97: 10002–10007.
Gardiol D, Kuhne C, Glaunsinger B, Lee SS, Javier R, Banks L . (1999). Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 18: 5487–5496.
Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ . (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140–144.
Hebner CM, Laimins LA . (2006). Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev Med Virol 16: 83–97.
Huibregtse JM, Scheffner M, Howley PM . (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J 10: 4129–4135.
Jiang M, Milner J . (2002). Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21: 6041–6048.
Kim VN . (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376–385.
Kohlberger P, Beneder C, Horvat R, Leodolter S, Breitenecker G . (2003). Immunohistochemical expression of laminin-5 in cervical intraepithelial neoplasia. Gynecol Oncol 89: 391–394.
Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA . (1992). Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 11: 3045–3052.
Lewis BP, Burge CB, Bartel DP . (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20.
Livak KJ, Schmittgen TD . (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) Method. Methods 25: 402–408.
Manos MM, Waldman J, Zhang TY, Greer CE, Eichinger G, Schiffman MH et al. (1994). Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis 170: 1096–1099.
Martinez I, Wang J, Hobson KF, Ferris RL, Khan SA . (2007). Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur J Cancer 43: 415–432.
Massimi P, Pim D, Storey A, Banks L . (1996). HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation. Oncogene 12: 2325–2330.
Meissner JD . (1999). Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 80: 1725–1733.
Munger K, Howley PM . (2002). Human papillomavirus immortalization and transformation functions. Virus Res 89: 213–228.
Piboonniyom SO, Duensing S, Swilling NW, Hasskarl J, Hinds PW, Munger K . (2003). Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Res 63: 476–483.
Skyldberg B, Salo S, Eriksson E, Aspenblad U, Moberger B, Tryggvason K et al. (1999). Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst 91: 1882–1887.
Stanley MA, Browne HM, Appleby M, Minson AC . (1989). Properties of a non-tumorigenic human cervical keratinocyte cell line. Int J Cancer 43: 672–676.
Tang S, Tao M, McCoy Jr JP, Zheng ZM . (2006). The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J Virol 80: 4249–4263.
Thomas M, Pim D, Banks L . (1999). The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18: 7690–7700.
Xi Y, Shalgi R, Fodstad O, Pilpel Y, Ju J . (2006). Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 12: 2014–2024.
Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A et al. (2006). MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103: 9136–9141.
zur Hausen H . (2002). Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342–350.
Acknowledgements
We thank Stefan Duensing and Karl Munger for U2OS and NOK cell lines, Margaret Stanley and Paul Lambert for W12-derived cell lines, Cathy Ma for help with standardization of miRNA microarrays, Naftali Kaminski for the use of the GenePix Scanner and Yugandhar Reddy for helpful discussions. This work was supported in part by National Institutes of Health Grant DC016406 to SAK. ASG was supported by NIH training grant 5T32GM065100 (Biotechnology Training Grant) and by NIH Ruth Kirschstein predoctoral fellowship DE019028.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc).
Rights and permissions
About this article
Cite this article
Martinez, I., Gardiner, A., Board, K. et al. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27, 2575–2582 (2008). https://doi.org/10.1038/sj.onc.1210919
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1210919
Keywords
This article is cited by
-
Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro
Clinical and Translational Oncology (2020)
-
MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy
BMC Cancer (2019)
-
Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells
Scientific Reports (2019)
-
MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via LYN/NF-κB signaling pathway
Cancer Cell International (2018)
-
HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys
Oncogene (2018)